University of Michigan Rogel Cancer Center: all 322 studies
Page 1 of 4. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell TherapyRecruitingNCT07892027Phase 2
- Transcranial Direct Current Stimulation to Improve Gait for Breast Cancer Survivor's Who Received Taxene and/or Platinum ChemotherapyNot yet recruitingNCT07864792Not applicable
- An Artificial Intelligence-Powered Supportive Care Chatbot to Address the Supportive Care Needs of Young Adult Cancer SurvivorsRecruitingNCT07772596Not applicable
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic SyndromeNot yet recruitingNCT07737769Phase 1
- Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT07682649Phase 1
- Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer SurvivorsRecruitingNCT07673614Not applicable
- Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerRecruitingNCT07645391
- Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial CarcinomaRecruitingNCT07630155Not applicable
- A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American FamiliesNot yet recruitingNCT07542405Not applicable
- Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or LymphomaRecruitingNCT07532525Phase 1
- Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA TrialNot yet recruitingNCT07529080Not applicable
- Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE TrialRecruitingNCT07526545Not applicable
- SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among UltrarunnersNot yet recruitingNCT07481344Not applicable
- A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS TrialRecruitingNCT07443943Phase 2
- A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatmentRecruitingNCT07365007Not applicable
- A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer PatientsRecruitingNCT07291414Not applicable
- Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialRecruitingNCT07158021Phase 2
- An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine CancerRecruitingNCT07132645Early Phase 1
- Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT TrialRecruitingNCT07121595Phase 2
- SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) TherapyRecruitingNCT07096999
- Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck CancerRecruitingNCT07094685Phase 2
- Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer SurvivorsRecruitingNCT06941324Not applicable
- Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer SyndromesRecruitingNCT06927947Not applicable
- CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast CancerRecruitingNCT06915168Not applicable
- Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain TumorsRecruitingNCT06914479Phase 1
- Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON TrialRecruitingNCT06866262Phase 1/2
- Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell TransplantationRecruitingNCT06784336Phase 2
- Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)RecruitingNCT06641310Not applicable
- Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate CancerRecruitingNCT06616155Phase 1/2
- Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial CancerRecruitingNCT06356155Phase 2
- Gilteritinib for the Treatment of ALK NSCLCRecruitingNCT06225427Phase 1
- Breast Cancer Resiliency Through Exercise Program (B-REP)RecruitingNCT06100263Not applicable
- Living Well With LymphomaRecruitingNCT06047626Not applicable
- Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic ProbeRecruitingNCT05965180
- Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell LymphomasRecruitingNCT05956041Phase 2
- Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell TransplantationRecruitingNCT05945121Not applicable
- A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaRecruitingNCT05901519Phase 2
- A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)RecruitingNCT05894083Phase 2
- Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant RecipientsRecruitingNCT05866302
- Metastatic Leiomyosarcoma Biomarker ProtocolRecruitingNCT05653388
- Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With CancerRecruitingNCT05183126Phase 4
- Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])RecruitingNCT05038332Phase 2
- Localized Leiomyosarcoma Biomarker ProtocolRecruitingNCT04925089
- Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative NeoplasmsRecruitingNCT04858256Phase 2
- Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid CancerRecruitingNCT03099356Phase 2
- Quantitative MRI for MyelofibrosisRecruitingNCT01973881
- Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and AdenomasRecruitingNCT00843375
- Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer SurvivorsCompletedNCT06442891Not applicableResults posted
- Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer SurvivorsCompletedNCT06046014Not applicableResults posted
- Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot StudyCompletedNCT05764005Not applicableResults posted
- Michigan Genetic Hereditary Testing (MiGHT)CompletedNCT05162846Not applicableResults posted
- Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate CancerActive, not recruitingNCT04848337Phase 2Results posted
- Lighting Intervention for Cancer-related FatigueCompletedNCT04827446Not applicableResults posted
- Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated ArthralgiasCompletedNCT04754399Phase 2Results posted
- Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve InterfaceCompletedNCT04530526Not applicableResults posted
- Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology PatientsTerminatedNCT04503668Phase 3Results posted
- Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line TherapyTerminatedNCT04497038Phase 1/2Results posted
- Mycophenolate Mofetil Combined With Radiation Therapy in GlioblastomaActive, not recruitingNCT04477200Phase 1Results posted
- Altering Lipids for Tolerance of Aromatase Inhibitor TherapyCompletedNCT04268134Phase 2Results posted
- Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)TerminatedNCT04203160Phase 1/2Results posted
- Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based TherapyActive, not recruitingNCT04140162Phase 2Results posted
- Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell TransplantationCompletedNCT04094844Not applicableResults posted
- Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic SarcomaCompletedNCT04076579Phase 2Results posted
- Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell LymphomaCompletedNCT03927105Phase 2Results posted
- Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck CancerCompletedNCT03829722Phase 2Results posted
- Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)Active, not recruitingNCT03787680Phase 2Results posted
- Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract CancerCompletedNCT03785873Phase 1/2Results posted
- Acupressure for Fatigue in Ovarian Cancer SurvivorsCompletedNCT03763838Not applicableResults posted
- Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate CancerTerminatedNCT03689582Phase 2Results posted
- Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum TherapyCompletedNCT03639935Phase 2Results posted
- The ConnectedCancerCare Pilot Study (CCC)CompletedNCT03618017Not applicableResults posted
- Immunotherapy in Patients With Metastatic Cancers and CDK12 MutationsCompletedNCT03570619Phase 2Results posted
- Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT03562507Phase 2Results posted
- Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung CancerTerminatedNCT03559049Phase 1/2Results posted
- FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)CompletedNCT03556904Phase 2Results posted
- Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)TerminatedNCT03547700Phase 1/2Results posted
- Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx CancerCompletedNCT03416153Phase 2Results posted
- Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) AlterationsTerminatedNCT03352427Phase 2Results posted
- ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate CancerTerminatedNCT03300505Phase 1Results posted
- Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial CarcinomaTerminatedNCT03287050Phase 2Results posted
- Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With PembrolizumabTerminatedNCT03286114Phase 1Results posted
- Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted AgentsCompletedNCT03242915Phase 2Results posted
- Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial CancerCompletedNCT03240016Phase 2Results posted
- Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung CancerTerminatedNCT03228186Phase 2Results posted
- Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT03194373Phase 2Results posted
- Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract CancerCompletedNCT03101566Phase 2Results posted
- Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell CancerCompletedNCT02989714Phase 1/2Results posted
- Vessel Sparing Prostate Radiation TherapyCompletedNCT02958787Phase 2Results posted
- A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With GlioblastomaCompletedNCT02805179Phase 2Results posted
- Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell CancerCompletedNCT02784288Phase 2Results posted
- Genomics in Michigan Impacting Observation or RadiationCompletedNCT02783950Not applicableResults posted
- Expansion Trial for Axitinib In Head And Neck CancerCompletedNCT02762513Phase 2Results posted
- Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell CarcinomaCompletedNCT02729194Early Phase 1Results posted
- A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung CancerCompletedNCT02492867Not applicableResults posted
- A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular CarcinomaCompletedNCT02460835Not applicableResults posted
- VISmodegib for ORbital and Periocular Basal Cell CarcinomaCompletedNCT02436408Phase 4Results posted
- A Pilot Study of Ruxolitinib in Secondary Hemophagocytic SyndromeCompletedNCT02400463Phase 2Results posted
- Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple MyelomaCompletedNCT02331368Phase 2Results posted
- Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid LeukemiaCompletedNCT02328755Phase 1/2Results posted
- Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell LymphomasCompletedNCT02158975Phase 2Results posted
← University of Michigan Rogel Cancer Center overview and focus areas